TCG Crossover Management, LLC 13F Portfolio
| Entity | Category | QoQ AUM Change | AUM (13F) | # of Holdings | Performance Rank | Equities Trend |
|---|---|---|---|---|---|---|
TC TCG Crossover Management, LLC | Institutional Filer | ▲ 15.68% | $3.50B | 49 |
Current Portfolio Holdings
Showing all 49 reported positions by value
| # | Stock | Company Name | Sector | Shares Held | Market Value | % of Portfolio |
|---|---|---|---|---|---|---|
| 1 | ABVX | Abivax S.A. | Healthcare | 6.5M | $721.7M | 20.65% |
| 2 | CGON | CG Oncology, Inc. Common stock | Healthcare | 3.7M | $248.4M | 7.11% |
| 3 | TNGX | Tango Therapeutics, Inc. | Healthcare | 10.5M | $220.3M | 6.30% |
| 4 | COGT | Cogent Biosciences, Inc. | Healthcare | 4.9M | $190.4M | 5.45% |
| 5 | CNTA | Centessa Pharmaceuticals plc | Healthcare | 4.3M | $170.3M | 4.87% |
| 6 | DNTH | Dianthus Therapeutics, Inc. | Healthcare | 1.7M | $140.7M | 4.03% |
| 7 | TYRA | Tyra Biosciences, Inc. | Healthcare | 3.2M | $124.4M | 3.56% |
| 8 | IMVT | Immunovant, Inc. | Healthcare | 4.5M | $110.7M | 3.17% |
| 9 | BCRX | BioCryst Pharmaceuticals, Inc. | Healthcare | 11.0M | $104.9M | 3.00% |
| 10 | MIRM | Mirum Pharmaceuticals, Inc. | Healthcare | 1.1M | $98.1M | 2.81% |
| 11 | VOR | Vor Biopharma Inc. | Healthcare | 5.7M | $96.5M | 2.76% |
| 12 | SYRE | Spyre Therapeutics, Inc. | Healthcare | 1.9M | $95.9M | 2.74% |
| 13 | AMLX | Amylyx Pharmaceuticals, Inc. | Healthcare | 6.2M | $86.8M | 2.48% |
| 14 | IRON | Disc Medicine, Inc. | Healthcare | 1.3M | $85.8M | 2.45% |
| 15 | DYN | Dyne Therapeutics, Inc. | Healthcare | 4.6M | $83.7M | 2.39% |
Showing 1 to 15 of 49 holdings